Envoy Medical (NASDAQ:COCH) versus Owlet (NYSE:OWLT) Head-To-Head Survey

Envoy Medical (NASDAQ:COCH) and Owlet (NYSE:OWLT) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, institutional ownership, profitability and earnings.

Analyst Ratings

This is a breakdown of current recommendations for Envoy Medical and Owlet, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1	1	2	0	2.25
Owlet	1	1	3	0	2.40

Envoy Medical presently has a consensus target price of $21.67, indicating a potential upside of 233.33%. Owlet has a consensus target price of $15.00, indicating a potential upside of 257.57%. Given Owlet’s stronger consensus rating and higher probable upside, analysts plainly believe Owlet is more favorable than Envoy Medical.

Profitability

This table compares Envoy Medical and Owlet’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-11,304.83%	N/A	-144.13%
Owlet	-8.61%	-601.24%	-15.96%

Valuation and Earnings

This table compares Envoy Medical and Owlet”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$240,000.00	209.08	-$23.76 million	($0.76)	-8.55
Owlet	$105.70 million	1.16	-$39.68 million	($0.75)	-5.59

Envoy Medical has higher earnings, but lower revenue than Owlet. Envoy Medical is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Envoy Medical has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500. Comparatively, Owlet has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500.

Institutional and Insider Ownership

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 72.6% of Owlet shares are held by institutional investors. 7.2% of Envoy Medical shares are held by insiders. Comparatively, 36.2% of Owlet shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Owlet beats Envoy Medical on 9 of the 14 factors compared between the two stocks.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About Owlet

Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.